Epiregulin (EREG) and amphiregulin (AREG) gene expression to predict response to cetuximab therapy in combination with oxaliplatin (Ox) and 5FU in first-line treatment of advanced colorectal cancer (aCRC).
Epiregulin (EREG) and amphiregulin (AREG) gene expression to predict response to cetuximab therapy in combination with oxaliplatin (Ox) and 5FU in first-line treatment of advanced colorectal cancer (aCRC).
Adams RA., Fisher D., Farragher S., Scott A., Smith CG., James MD., Cheadle J., Nichols LL., Meade AM., Kaplan RS., Wilson RH., Wasan HS., Maughan T.
